The FDA has approved Susvimo (ranibizumab injection) for the treatment of patients with diabetic macular edema.

Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing ...

It's a daycare procedure and doesn't require hospitalisation. However, it is an expensive treatment. Will my health insurance cover the expenses? -Name withheld on request Insurance coverage for ...

As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...

Insurance coverage for intravitreal injections, an essential treatment for diabetic retinopathy, depends on the specific terms and conditions of an individual’s health insurance policy.

Diabetic nephropathy (DN) and diabetic retinopathy (DR) are microvascular complications of diabetes. Microvascular endothelial cells are thought to be the major targets of hyperglycemic injury. In ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvimo® (ranibizumab injection) 100 mg/mL for the treatment of diabetic macular edema ...

Fundus photography involves taking a photo of the back of the eye to detect signs of diabetic retinopathy. It is also possible to capture an image of the retina using a smartphone. Diabetic ...

However, treating diabetic retinopathy in clinical practice mainly focuses on the intermediate and late ... and vitreous corticosteroids may lead to increased intraocular pressure and secondary ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Diabetic retinopathy is a ...

The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...